13D Filing: Aisling Capital III LP and Pernix Therapeutics Holdings Inc. (PTX)

CUSIP No. 71426V108

SCHEDULE  13D

Page 9 of 11

(c)           No Reporting Person nor, to the best knowledge of each Reporting Person, any person identified in Item 2 of this Schedule 13D, has effected any transaction in shares of Common Stock during the preceding 60 days.

(d)           The partners of Aisling have the right to participate in the receipt of dividends from, or proceeds from the sale of, the shares of Common Stock held for the account of Aisling in accordance with their ownership interests in Aisling.

(e)           As of July 30, 2016, the Reporting Persons ceased to beneficially own more than 5% of the Common Stock of the Issuer due to dilution of their holdings resulting from the issuance of additional shares of Common Stock by the Issuer.

Item 6.     Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

No material change.